Press/Media
- 725 - 750 out of 2,094 results
Search results
-
Mesoblast (MSB: 93.50c) weakens below moving average price
3/11/22
1 item of Media coverage
Press/Media
-
New tool discovered for estimating people’s total exposure to potentially harmful chemicals
3/11/22
1 item of Media coverage
Press/Media
-
New tool discovered for estimating people's total exposure to potentially harmful chemicals
3/11/22
1 item of Media coverage
Press/Media
-
DSCC: Oz's Medical Research Was Rejected In 2003, Resulting In 2-Year Ban
2/11/22
1 item of Media coverage
Press/Media
-
A New Tool for Estimating People’s Total Exposure to Potentially Harmful Chemicals Is Developed by Mount Sinai Researchers
2/11/22
1 item of Media coverage
Press/Media
-
Study finds persistent disparities in access to prenatal care among pregnant people based on citizenship status and education level
Ashley Fox & Teresa Janevic
2/11/22
1 item of Media coverage
Press/Media
-
A new tool for estimating people’s total exposure to potentially harmful chemicals is developed by Mount Sinai researchers
2/11/22
5 items of Media coverage
Press/Media
-
Senate candidate Mehmet Oz’s medical research was rejected in 2003, resulting in 2-year ban
1/11/22
1 item of Media coverage
Press/Media
-
Dr. Oz Called Mitch McConnell The ‘Leader Of The Republican Party,’ Med Colleague Says
1/11/22
1 item of Media coverage
Press/Media
-
Dr Oz asks surgeon to downplay candidate’s role in research that allegedly killed puppies
1/11/22
3 items of Media coverage
Press/Media
-
Mesoblast (MSB: 94.0c) inches higher, resistance at 12-day EMA
1/11/22
1 item of Media coverage
Press/Media
-
Oz research rejected from 2003 surgery convention, resulted in 2-year ban & More Latest News
1/11/22
1 item of Media coverage
Press/Media
-
Dr. Oz Called Mitch McConnell The 'Leader Of The Republican Party,' Med Colleague Says
1/11/22
1 item of Media coverage
Press/Media
-
Dr Oz asks surgeon to downplay candidate's role in research that allegedly killed puppies
1/11/22
1 item of Media coverage
Press/Media
-
Dr. Oz's Research Supervisor Declined His Request to Deny That His Studies Killed Puppies
1/11/22
2 items of Media coverage
Press/Media
-
Mehmet Oz’s medical research was rejected in 2003, resulting in 2-year ban
1/11/22
1 item of Media coverage
Press/Media
-
Monthly: Mesoblast (MSB: 92.50c) rises 17% on high volatility in October 2022
1/11/22
1 item of Media coverage
Press/Media
-
Mount Sinai Health System: Study Finds Persistent Disparities in Access to Prenatal Care Among Pregnant People Based on Citizenship Status and Education Level
Ashley Fox & Teresa Janevic
28/10/22 → 29/10/22
2 items of Media coverage
Press/Media
-
Weekly: Mesoblast (MSB: 88.50c) in bottom 5% performers of All Ordinaries Index in past week; -8c [8.3%]
29/10/22
1 item of Media coverage
Press/Media
-
Study finds persistent disparities in access to prenatal care among pregnant people
Ashley Fox & Teresa Janevic
28/10/22
1 item of Media coverage
Press/Media
-
Study finds persistent disparities in access to prenatal care among pregnant people based on citizenship status and education level
Ashley Fox & Teresa Janevic
27/10/22 → 28/10/22
5 items of Media coverage
Press/Media
-
VIDEO: CT can play a role in identifying women's differences in cardiovascular presentations
27/10/22
1 item of Media coverage
Press/Media
-
Mesoblast (MSB: 93.0c) keeps sliding, down 9.3% in 5 days
26/10/22
1 item of Media coverage
Press/Media
-
Mesoblast (MSB: 94.0c) weakens below moving average price
25/10/22
1 item of Media coverage
Press/Media
-
Mesoblast (MSB: 94.50c) decreases 2.1% weakening below moving average price
24/10/22
1 item of Media coverage
Press/Media